$IMAQ
International Media Acquisition Corp. Stock $imaq

$imaq Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000165495424007239 Filed on June 03, 2024

Income Statement

Concept	2024 Q2	2023 Q4
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$731.6K
YoY Change		7.27%
Operating Profit	-$270.9K	-$731.6K
YoY Change	-328.09%	7.27%
Interest Expense		$286.7K
YoY Change		56.22%
% of Operating Profit
Other Income/Expense, Net		-$12.75K
YoY Change
Pretax Income	-$127.2K	-$457.6K
YoY Change	-133.58%	-8.2%
Income Tax	$27.69K	$19.34K
% Of Pretax Income
Net Earnings	-$154.9K	-$476.9K
YoY Change	-148.0%	-9.13%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02
Diluted Earnings Per Share	-$0.02	-$0.06
COMMON SHARES
Basic Shares Outstanding	7.522M shares
Diluted Shares Outstanding	7.522M shares

Balance Sheet

Concept	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.180K
YoY Change		-99.26%
Cash & Equivalents	$247.00	$1.177K
Short-Term Investments
Other Short-Term Assets		$0.00
YoY Change
Inventory
Prepaid Expenses	$62.26K	$0.00
Receivables
Other Receivables	$10.00K
Total Short-Term Assets	$72.51K	$1.177K
YoY Change	-67.12%	-99.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$22.03M
YoY Change		-0.37%
Other Assets
YoY Change
Total Long-Term Assets	$11.59M	$22.03M
YoY Change	-45.79%	-0.37%
TOTAL ASSETS
Total Short-Term Assets	$72.51K	$1.177K
Total Long-Term Assets	$11.59M	$22.03M
Total Assets	$11.66M	$22.03M
YoY Change	-46.01%	-1.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$1.943M
YoY Change		95.25%
Accrued Expenses		$6.910K
YoY Change		-95.94%
Deferred Revenue
YoY Change
Short-Term Debt		$3.019M
YoY Change		76.53%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.800M	$5.965M
YoY Change	70.54%	96.68%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$8.079M
YoY Change		0.06%
Total Long-Term Liabilities		$8.079M
YoY Change		0.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.800M	$5.965M
Total Long-Term Liabilities		$8.079M
Total Liabilities	$14.89M	$14.04M
YoY Change	23.52%	26.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.30M	-$13.28M
YoY Change	31.43%	24.81%
Common Stock	$655.00	$655.00
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$14.30M	-$13.28M
YoY Change
Total Liabilities & Shareholders Equity	$11.66M	$22.03M
YoY Change	-46.01%	-1.08%

Cashflow Statement

Concept	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	-$154.9K	-$476.9K
YoY Change	-148.0%	-9.13%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$431.6K	-$323.3K
YoY Change	78.12%	128.17%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$385.5K
YoY Change		10.15%
Cash From Investing Activities	-$80.00K	-$385.5K
YoY Change	-48.75%	10.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$510.8K	702.9K
YoY Change	-12.47%	23.32%
NET CHANGE
Cash From Operating Activities	-$431.6K	-323.3K
Cash From Investing Activities	-$80.00K	-385.5K
Cash From Financing Activities	$510.8K	702.9K
Net Change In Cash	-$797.00	-5.890K
YoY Change	-100.43%	-107.52%
FREE CASH FLOW
Cash From Operating Activities	-$431.6K	-$323.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	imac	Related Party Current Liabilities RelatedPartyCurrentLiabilities	0	usd
CY2023Q1	imac	Related Party Current Liabilities RelatedPartyCurrentLiabilities	200000	usd
CY2023Q4	imac	Due To Related Party Current DueToRelatedPartyCurrent	649913	usd
CY2023Q1	imac	Due To Related Party Current DueToRelatedPartyCurrent	0	usd
CY2023Q4	imac	Promissory Note Related Party PromissoryNoteRelatedParty	2445000	usd
CY2023Q1	imac	Promissory Note Related Party PromissoryNoteRelatedParty	2125541	usd
CY2023Q4	imac	Loan Jc Unify LoanJcUnify	573673	usd
CY2023Q1	imac	Loan Jc Unify LoanJcUnify	0	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6906	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	0	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	346446	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	207632	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5964689	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3725880	usd
CY2023Q4	imac	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	8050000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-524827	usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40687
	dei	Entity Registrant Name EntityRegistrantName	INTERNATIONAL MEDIA ACQUISITION CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-1627460
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1604 US Highway 130
	dei	Entity Address City Or Town EntityAddressCityOrTown	N Brunswick
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08902
	imac	Underwriting Cash Discount Per Unit UnderwritingCashDiscountPerUnit	0.20
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	960‑3677
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7522430	shares
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1177	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	302	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	52500	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1177	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	52802	usd
CY2023Q4	us-gaap	Investments Investments	22027582	usd
CY2023Q1	us-gaap	Investments Investments	20978456	usd
CY2023Q4	us-gaap	Assets Assets	22028759	usd
CY2023Q1	us-gaap	Assets Assets	21031258	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1942751	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1192707	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001846235
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6546900	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6546900	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1909723	shares
	imac	Months To Complete Acquisition MonthsToCompleteAcquisition	P12M
	imac	Maximum Extended Months To Complete Acquisition MaximumExtendedMonthsToCompleteAcquisition	P126D
	imac	Threshold Business Days For Redemption Of Public Shares ThresholdBusinessDaysForRedemptionOfPublicShares	P10D
CY2022Q3	imac	Extension Period For Combination ExtensionPeriodForCombination	P3M
	imac	Offering Costs Incurred OfferingCostsIncurred	0	usd
	imac	Offering Costs Incurred OfferingCostsIncurred	0	usd
	dei	Document Type DocumentType	10-Q
CY2023Q1	imac	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	8050000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	28688	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	23907	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14043377	usd
CY2023Q1	us-gaap	Liabilities Liabilities	11799787	usd
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1909723	shares
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1973118	shares
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	11.13
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.28
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	21263402	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	20284026	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6546900	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	655	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	655	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13278675	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11053211	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-13278020	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-11052556	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22028759	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21031258	usd
CY2023Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	731550	usd
CY2022Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	681987	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1417531	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1872212	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-731550	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-681987	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1417531	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1872212	usd
CY2023Q4	imac	Liabilities Written Back LiabilitiesWrittenBack	0	usd
CY2022Q4	imac	Liabilities Written Back LiabilitiesWrittenBack	0	usd
	imac	Liabilities Written Back LiabilitiesWrittenBack	200000	usd
	imac	Liabilities Written Back LiabilitiesWrittenBack	0	usd
CY2023Q4	imac	Warrant Liability At Fair Value Changes In Fair Value WarrantLiabilityAtFairValueChangesInFairValue	-12750	usd
CY2022Q4	imac	Warrant Liability At Fair Value Changes In Fair Value WarrantLiabilityAtFairValueChangesInFairValue	0	usd
	imac	Warrant Liability At Fair Value Changes In Fair Value WarrantLiabilityAtFairValueChangesInFairValue	-4781	usd
	imac	Warrant Liability At Fair Value Changes In Fair Value WarrantLiabilityAtFairValueChangesInFairValue	119535	usd
CY2023Q4	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	286712	usd
CY2022Q4	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	183534	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	812558	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	862210	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-457588	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-498453	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-409754	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-890467	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19340	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26374	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	138814	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	157656	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-476928	usd
	us-gaap	Net Income Loss NetIncomeLoss	-548568	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1048123	usd
CY2023Q4	imac	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	8456623	shares
CY2022Q4	imac	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	8688795	shares
	imac	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	8485669	shares
	imac	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	17443109	shares
CY2023Q4	imac	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.06
CY2022Q4	imac	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.06
	imac	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.06
	imac	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.06
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-11052556	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	322616	usd
CY2023Q2	imac	Accretion Of Class A Ordinary Shares Subject To Redemption AccretionOfClassAOrdinarySharesSubjectToRedemption	-149071	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-10879009	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-394256	usd
CY2023Q3	imac	Accretion Of Class A Ordinary Shares Subject To Redemption AccretionOfClassAOrdinarySharesSubjectToRedemption	-275850	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11549116	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-476928	usd
CY2023Q4	imac	Accretion Of Class A Ordinary Shares Subject To Redemption AccretionOfClassAOrdinarySharesSubjectToRedemption	-1245070	usd
CY2023Q4	imac	Excise And Sales Taxe ExciseAndSalesTaxe	6906	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-13278020	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-8552598	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-204672	usd
CY2022Q2	imac	Accretion Of Class A Ordinary Shares Subject To Redemption AccretionOfClassAOrdinarySharesSubjectToRedemption	-340524	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-9097794	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-318624	usd
CY2022Q3	imac	Accretion Of Class A Ordinary Shares Subject To Redemption AccretionOfClassAOrdinarySharesSubjectToRedemption	-368089	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-9784507	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-524827	usd
CY2022Q4	imac	Accretion Of Class A Ordinary Shares Subject To Redemption AccretionOfClassAOrdinarySharesSubjectToRedemption	-329380	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10638714	usd
	us-gaap	Net Income Loss NetIncomeLoss	-548568	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1048123	usd
	imac	Interest And Dividend Income On Investments Held In Trust Account InterestAndDividendIncomeOnInvestmentsHeldInTrustAccount	812558	usd
	imac	Interest And Dividend Income On Investments Held In Trust Account InterestAndDividendIncomeOnInvestmentsHeldInTrustAccount	862210	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	4781	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-119535	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-52500	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-192200	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	550044	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	671014	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	138814	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	157656	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-614986	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1008998	usd
	imac	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	1028109	usd
	imac	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	700000	usd
	imac	Proceeds From Trust Account To Pay Franchise Tax ProceedsFromTrustAccountToPayFranchiseTax	100925	usd
	imac	Proceeds From Trust Account To Pay Franchise Tax ProceedsFromTrustAccountToPayFranchiseTax	245267	usd
	imac	Proceeds From Trust Account In Connection With Redemption ProceedsFromTrustAccountInConnectionWithRedemption	690615	usd
	imac	Proceeds From Trust Account In Connection With Redemption ProceedsFromTrustAccountInConnectionWithRedemption	209237593	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-236569	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	208782860	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	573673	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	319459	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1515000	usd
	imac	Proceeds From Advance From Sponsor ProceedsFromAdvanceFromSponsor	649913	usd
	imac	Proceeds From Advance From Sponsor ProceedsFromAdvanceFromSponsor	0	usd
	imac	Proceeds From Issuance Of Redemption Of Common Stock ProceedsFromIssuanceOfRedemptionOfCommonStock	-690615	usd
	imac	Proceeds From Issuance Of Redemption Of Common Stock ProceedsFromIssuanceOfRedemptionOfCommonStock	-209237593	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	852430	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-207722593	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	875	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	51268	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	302	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	107684	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1177	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158952	usd
	imac	Accretion Of Public Shares To Redemption Value AccretionOfPublicSharesToRedemptionValue	1669991	usd
	imac	Accretion Of Public Shares To Redemption Value AccretionOfPublicSharesToRedemptionValue	1037993	usd
CY2021Q3	imac	Condition For Future Business Combination Threshold Net Tangible Assets ConditionForFutureBusinessCombinationThresholdNetTangibleAssets	5000001	usd
	imac	Redemption Limit Percentage Without Prior Consent RedemptionLimitPercentageWithoutPriorConsent	20	pure
CY2022Q3	imac	Months To Complete Acquisition MonthsToCompleteAcquisition	P12M
	imac	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
CY2023Q1	imac	Trust Account Deposits TrustAccountDeposits	350000	usd
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	21026882	shares
CY2023Q1	imac	Stock Held In Public Stockholdersshares StockHeldInPublicStockholdersshares	23000000	shares
CY2023Q1	imac	Redemption Price Per Share RedemptionPricePerShare	10.03
CY2023Q3	imac	Public Stockholdersshares PublicStockholdersshares	63395	shares
CY2023Q3	imac	Stock Held In Public Stockholdersshares StockHeldInPublicStockholdersshares	1973118	shares
CY2023Q3	imac	Redemption Price Per Share RedemptionPricePerShare	10.89
CY2022Q3	us-gaap	Interest Expense Demand Deposit Accounts InterestExpenseDemandDepositAccounts	350000	usd
CY2022Q4	us-gaap	Interest Expense Demand Deposit Accounts InterestExpenseDemandDepositAccounts	350000	usd
CY2023Q1	us-gaap	Interest Expense Demand Deposit Accounts InterestExpenseDemandDepositAccounts	385541	usd
CY2023Q2	us-gaap	Interest Expense Demand Deposit Accounts InterestExpenseDemandDepositAccounts	128513	usd
CY2023Q2	us-gaap	Interest Expense Demand Deposit Accounts InterestExpenseDemandDepositAccounts	128513	usd
CY2023Q3	us-gaap	Interest Expense Demand Deposit Accounts InterestExpenseDemandDepositAccounts	128513	usd
	us-gaap	Interest Expense Demand Deposit Accounts InterestExpenseDemandDepositAccounts	128513	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1177	usd
CY2023Q4	imac	Working Capital Deficit WorkingCapitalDeficit	5963512	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	6906	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.</p>
CY2023Q4	us-gaap	Cash Cash	1177	usd
CY2023Q1	us-gaap	Cash Cash	302	usd
CY2023Q4	imac	Deferred Fee Per Unit DeferredFeePerUnit	0.35
CY2023Q4	imac	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	8050000	usd
	imac	Period For Right Of First Refusal To Act As Book Running Manager After Date Of Consummation Of Business Combination PeriodForRightOfFirstRefusalToActAsBookRunningManagerAfterDateOfConsummationOfBusinessCombination	P18M
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1452	pure
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0529	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.3388	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1771	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	17847675	shares
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-476928	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-524827	usd
	us-gaap	Net Income Loss NetIncomeLoss	-548568	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1048123	usd
CY2023Q4	imac	Basic And Diluted Weighted Average Shares Outstanding BasicAndDilutedWeightedAverageSharesOutstanding	8456623	shares
CY2022Q4	imac	Basic And Diluted Weighted Average Shares Outstanding BasicAndDilutedWeightedAverageSharesOutstanding	8688795	shares
	imac	Basic And Diluted Weighted Average Shares Outstanding BasicAndDilutedWeightedAverageSharesOutstanding	8485669	shares
	imac	Basic And Diluted Weighted Average Shares Outstanding BasicAndDilutedWeightedAverageSharesOutstanding	17443109	shares
CY2023Q4	imac	Basic And Diluted Net Loss Per Share Of Common Stock BasicAndDilutedNetLossPerShareOfCommonStock	-0.06
CY2022Q4	imac	Basic And Diluted Net Loss Per Share Of Common Stock BasicAndDilutedNetLossPerShareOfCommonStock	-0.06
	imac	Basic And Diluted Net Loss Per Share Of Common Stock BasicAndDilutedNetLossPerShareOfCommonStock	-0.06
	imac	Basic And Diluted Net Loss Per Share Of Common Stock BasicAndDilutedNetLossPerShareOfCommonStock	-0.06
	imac	Percentage Of Economics For Future Public And Private Equity And Debt Offerings PercentageOfEconomicsForFuturePublicAndPrivateEquityAndDebtOfferings	0.30	pure
CY2021Q1	imac	Agreed To Pay Maximum Amount Subject To Successfully Completing Business Combination AgreedToPayMaximumAmountSubjectToSuccessfullyCompletingBusinessCombination	400000	usd
CY2021Q1	imac	Agreed To Pay Uncomplete Business Combination Within Combination Period AgreedToPayUncompleteBusinessCombinationWithinCombinationPeriod	40000	usd
CY2023Q4	us-gaap	Assets Under Management Carrying Amount AssetsUnderManagementCarryingAmount	40000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	786848	usd
CY2023Q4	imac	Securities Purchase Agreement With Buyer Description SecuritiesPurchaseAgreementWithBuyerDescription	the Sponsor, and Shibasish Sarkar, (“Seller”, together with the Sponsor the “Sellers”), pursuant to which the Sponsor agreed to sell, and the Buyer agreed to purchase, 4,125,000 Founder Shares and 657,675 private placement units of the Company, which represents 76% of the total Company Securities (as defined in the Securities Purchase Agreement) owned by the Sponsor for an aggregate purchase price of $1.00
CY2023Q4	imac	Related Parties Outstanding Amount RelatedPartiesOutstandingAmount	2445000	usd
CY2023Q1	imac	Related Parties Outstanding Amount RelatedPartiesOutstandingAmount	2125541	usd
CY2023Q4	imac	Loan Jc Unify LoanJcUnify	573673	usd
CY2023Q1	imac	Loan Jc Unify LoanJcUnify	0	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	360000	usd
	imac	Reimbursement Of Out Of Pocket Expenses ReimbursementOfOutOfPocketExpenses	25000	usd
CY2022Q1	imac	Percentage Of Fee Based On Target Introduced In Business Combination PercentageOfFeeBasedOnTargetIntroducedInBusinessCombination	0.005	pure
CY2022Q1	imac	Reimbursement Of Out Of Pocket Expenses ReimbursementOfOutOfPocketExpenses	25000	usd
	us-gaap	Sponsor Fees SponsorFees	38000	usd
	imac	Period For Not To Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination PeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination	P30D
CY2023Q4	imac	Number Of Warrants Issued NumberOfWarrantsIssued	23796900	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6546900	shares
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1973118	shares
	imac	Class Of Warrant Or Right Number Of Rights In Multiples Required To Receive Shares ClassOfWarrantOrRightNumberOfRightsInMultiplesRequiredToReceiveShares	20	shares
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	22027582	usd
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	28688	usd
CY2021Q3	us-gaap	Share Price SharePrice	10.00
CY2023Q4	us-gaap	Share Price SharePrice	10.00
CY2022Q4	us-gaap	Share Price SharePrice	10.00
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	9.44
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	11.32
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.20
	imac	Term To Business Combination Years TermToBusinessCombinationYears	P1Y
	imac	Term To Business Combination Years TermToBusinessCombinationYears	P0Y3M
	imac	Volatility Volatility	0.160	pure
	imac	Volatility Volatility	0.0351	pure
	us-gaap	Reinsurance Retention Policy Reinsured Risk Percentage ReinsuranceRetentionPolicyReinsuredRiskPercentage	0.0088	pure
	us-gaap	Reinsurance Retention Policy Reinsured Risk Percentage ReinsuranceRetentionPolicyReinsuredRiskPercentage	0.0384	pure
	us-gaap	Reinsurance Retention Policy Reinsured Risk Percentage ReinsuranceRetentionPolicyReinsuredRiskPercentage	0.0395	pure
CY2021Q3	us-gaap	Forward Contract Indexed To Equity Settlement Share Fair Value Per Share ForwardContractIndexedToEquitySettlementShareFairValuePerShare	0.58
CY2023Q4	us-gaap	Forward Contract Indexed To Equity Settlement Share Fair Value Per Share ForwardContractIndexedToEquitySettlementShareFairValuePerShare	0.03
CY2022Q4	us-gaap	Forward Contract Indexed To Equity Settlement Share Fair Value Per Share ForwardContractIndexedToEquitySettlementShareFairValuePerShare	0.03
	imac	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Beginning FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueBeginning	0	usd
	imac	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Initial Measurement FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInitialMeasurement	414352	usd
	imac	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Ending FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueEnding	462202	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-438295	usd
	imac	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Ending FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueEnding	23907	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	usd
	imac	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Ending FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueEnding	23907	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-7969	usd
	imac	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Ending FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueEnding	15938	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	12750	usd
CY2023Q4	imac	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Ending FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueEnding	28688	usd
	imac	Warrant Liability At Fair Value Changes In Fair Value WarrantLiabilityAtFairValueChangesInFairValue	-4781	usd
	imac	Withdrawal Funds From From Trust Account WithdrawalFundsFromFromTrustAccount	223743	usd

Files In Submission

Name	View Source	Status
0001654954-24-007239-index-headers.html	Edgar Link	pending
0001654954-24-007239-index.html	Edgar Link	pending
0001654954-24-007239.txt	Edgar Link	pending
0001654954-24-007239-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
imac-20231231.xsd	Edgar Link	pending
imac_10q.htm	Edgar Link	pending
imac_ex311.htm	Edgar Link	pending
imac_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
imac-20231231_def.xml	Edgar Link	unprocessable
imac-20231231_lab.xml	Edgar Link	unprocessable
imac-20231231_pre.xml	Edgar Link	unprocessable
imac_10q_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
imac-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IMAQ
International Media Acquisition Corp. Stock $imaq

2024 Q2 Form 10-Q Financial Statement

#000165495424007239 Filed on June 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMAQ International Media Acquisition Corp. Stock $imaq

2024 Q2 Form 10-Q Financial Statement

#000165495424007239 Filed on June 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMAQ
International Media Acquisition Corp. Stock $imaq